Form 4: Director Converts RSUs to Solventum Common Stock
Insider Transaction Report
Solventum Corp Director John H. Weiland converted 1,980 vested Restricted Stock Units into common stock on March 27, 2026.
Summary
- Director John H. Weiland converted 1,980 Restricted Stock Units (RSUs) into an equal number of Solventum Corp common shares.
- The transaction occurred on March 27, 2026, with a deemed acquisition price of $0 per share, indicating a non-cash conversion of vested equity awards.
- Following this conversion, Weiland's direct beneficial ownership of Solventum common stock increased to 5,544 shares.
- All 1,980 derivative Restricted Stock Units were disposed of in this conversion, resulting in zero RSUs beneficially owned by Weiland.
- The RSUs were fully vested and had an expiration date of May 13, 2034.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a routine conversion of vested equity awards by a director, with no immediate positive or negative implications for the company's operational or financial performance.
Positives
- Conversion of vested RSUs into common stock demonstrates a director's continued equity stake in the company.
Risks
- No specific risks related to the company's operations or financial health were mentioned in this Form 4 filing.
Future Outlook
No forward-looking statements or guidance were provided in this Form 4 filing, which primarily reports a past insider transaction.
Industry Context
StockSavvy.ai notes that the conversion of Restricted Stock Units into common stock is a standard practice for directors and executives receiving equity compensation. This transaction reflects the settlement of previously granted awards rather than a new investment decision, and it is common across various industries for executive compensation structures.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | John H. Weiland granted a Limited Power of Attorney to Megan Bombick and Kristen Brown to prepare and file Section 16 reports (Forms 3, 4, and 5) on his behalf for Solventum Corporation securities. | 03/06/2026 | This streamlines the process for insider trading compliance filings, ensuring timely and accurate reporting by the director. |
Stakeholder Impact
- Shareholders: The increase in common stock held by a director may be seen as a minor positive signal of alignment, though it is a routine conversion.
Key Dates
| Date | Description |
|---|---|
| 03/06/2026 | Execution date of the Limited Power of Attorney by John Weiland. |
| 03/27/2026 | Date of the transaction where Restricted Stock Units were converted to Common Stock. |
| 03/30/2026 | Date the Form 4 was signed by the attorney-in-fact for John H. Weiland. |
| 05/13/2034 | Expiration date of the Restricted Stock Units. |
Keywords
Solventum Corp, SOLV, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Stock Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.